🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This evening, a number of close friends and colleagues came together in Boston for a few hours to remember and pay tribute to Dr. Mikhail Blagosklonny, MD, PhD, who left us a few weeks ago after courageously battling lung cancer with brain metastases for two years. Misha had a

Honoring Mikhail Blagosklonnys' legacy - Wafik S. El-Deiry, MD, PhD, FACP HHMI Razelle Kurzrock, MD WIN Consortium oncodaily.com/blog/wafik-s-e… #CancerResearch #Cancer #HHMI #LungCancer #NCI #OncoDaily #Oncology #Medicine #MedEd #MedX #MedNews

Cure51 and WIN Consortium join forces to bring cancer research to a new level, rallying global oncologists, academics, leveraging data, cutting edge precision tech to make cancer a disease of the past. "A partnership with WIN is a huge step in the right direction,” Cure51

Great discussion at today’s WIN Consortium International Molecular Tumor Board about young patient with stage IV colorectal cancer, germline MSH2 and multiple driver mutations including PIK3CA, PTEN, beta-catenin, p53, FBXW7, SMARCB1 among others. Several good options for

Delighted to speak with Sendurai Mani and John Tarantino this morning about ways Iylon could collaborate with the WIN Consortium in advancing the field of Precision Oncology. Razelle Kurzrock, MD Catherine Bresson

Study to look at why some people with aggressive cancer are ‘super-survivors’ NHS centres join search for patients who have lived much longer than expected, in hope of developing new therapies theguardian.com/science/2024/n… It is great that Cure51 joined WIN Consortium recently.

A truly outstanding day at TargetCancer Fdn Foundation Think Tank focused on rare cancers and precision medicine. A lot of ground was covered across an array of topics. Razelle Kurzrock, MD Vivek Subbiah, MD WIN Consortium The Warren Alpert Medical School Legorreta Cancer Center at Brown University OncoDaily facebook.com/share/QtqGNyVu…

Super excited to be able to work on WIN Consortium manuscript (Bringing Next-Generation Precision Oncology to Patients) on long flight with WiFi as I come up on a year since being elected as the Chair. It has been a tremendous honor to work with colleagues including our CMO

Outstanding discussions at today’s WIN Consortium International Molecular Tumor Board with cases of advanced prostate cancer and thymoma presented by Dr. Sewanti Limaye Sewanti Limaye 🇮🇳🇺🇸 Razelle Kurzrock, MD Benedito A. Carneiro, MD, MS Liang Cheng, MD Global expertise and input brings out good options.

Great to speak with colleagues this morning at the National Cancer Center in Qatar about collaboration with the WIN Consortium about exciting directions for precision oncology clinical trials in the MENA region. #LegorretaCancerCenter The Warren Alpert Medical School

Outstanding meeting of the international WIN Consortium Data Science Committee with excellent discussions including of a number of exciting clinical studies of value to the global oncology and precision medicine communities.

Much input including new ideas to consider at a special WIN Consortium MTB discussion for a challenging case of aggressive glioblastoma treated with vaccines and immunotherapy. Drivers include PTEN deletion, EGFR amplification, EGFR vIII, CDKN2A/B, MTAP deletion. Technologies

Outstanding discussions at today’s international WIN Consortium Molecular Tumor Board for cases of colon cancer and lung cancer. The heterogeneity, drivers, and strategies are truly unique for each patient. Razelle Kurzrock, MD Sewanti Limaye 🇮🇳🇺🇸 Legorreta Cancer Center at Brown University #LegorretaCancerCenter

Captured by Razelle Kurzrock, MD We still use those land lines as we called them for a while but don’t leave a message if I’m not there to answer because I’m locked out of the voicemail.

Pleased to share WIN Consortium manuscript published today March 12, 2025 Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients oncotarget.com/article/28703/… oncotarget.com/article/28703/… Brown University Health

WIN Consortium latest manuscript on Bringing next-generation precision oncology to patients oncotarget.com/article/28703/ Wafik S. El-Deiry, MD, PhD, FACP Catherine Bresson Oncotarget Legorreta Cancer Center at Brown University Benedito A. Carneiro, MD, MS Pramesh CS Ruben A. Mesa, MD Khaled Musallam MD PhD Prof.Dr.Humaid Al-Shamsi 🇦🇪 Vall d’Hebron Institute of Oncology (VHIO) Sewanti Limaye 🇮🇳🇺🇸 Richard Schilsky Bill Dahut, MD

Excellent in depth discussions at the international WIN Consortium Molecular Tumor Board of challenging cases of breast cancer involving alterations in ER/PR+, multiple BRCA2 mutations, PTEN, ESR1 mutations, CDKN2A, MTAP loss and increased TMB and Her2 with AKT amplification.

Great discussions at today’s WIN Consortium international Molecular Tumor Board focused on Precision Oncology with cases from US (GBM), Spain (mCRC) and India (Esophageal Cancer). Razelle Kurzrock, MD Sewanti Limaye 🇮🇳🇺🇸 Christopher G. Azzoli Liang Cheng, MD

The WIN Consortium in Personalized Cancer Medicine is happy to collaborate and partner with colleagues in academia, foundations, government, pharma, advocacy groups, professional societies and other key stakeholders. #AACR25 ASCO AACR AACR President Lillian L. Siu Razelle Kurzrock, MD

Outstanding International WIN Consortium Molecular Tumor Board with participants from US, Canada, Spain, India and China to discuss thymic squamous cancer with liver & bone mets with Kit, BAP1, CDKN2A, CHEK2 mut, appendiceal cancer, GE junction cancer and CRC with adrenal mets.